Jeff Kent is Officer of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 83,586 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Jun 10, 2019, when has been sold 5,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83.6K
0% 3M change
0% 12M change
Total Value Held $0

Jeff Kent Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2019
BUY
Exercise of conversion of derivative security
-
5,000 Added 4.37%
109,330 Ordinary Shares
Jun 05 2019
BUY
Open market or private sale
$89,197 $24.64 p/Share
3,620 Added 3.35%
104,330 Ordinary Shares
Mar 23 2019
SELL
Payment of exercise price or tax liability
$77,299 $26.84 p/Share
2,880 Reduced 2.66%
105,580 Ordinary Shares
Mar 23 2019
BUY
Exercise of conversion of derivative security
-
6,500 Added 5.65%
108,460 Ordinary Shares
JK

Jeff Kent

Officer
Dublin, L2

Track Institutional and Insider Activities on HZNP

Follow Horizon Therapeutics Public Ltd Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP